Navigation Links
Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification
Date:5/18/2010

CLEVELAND, Ohio, May 18, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is proud to report that their ANGIO Mentor virtual reality simulator was used during the 4th International Congress of the Polish Vascular Societies in April 2010 for the training and certification of vascular physicians from medical centers across Poland.

The congress was organized by the Polish Society of Angiology, the Interventional Radiology Section of the Polish Medical Society of Radiology and the Polish Society of Vascular Surgery. The scientific program covered vascular and endovascular issues including patient management during and after the intervention, vascular malformations and children's vascular surgery. During the congress learners gained hands on practice on the ANGIO Mentor.

The Simbionix ANGIO Mentor is a multidisciplinary simulator that provides a complete and true-to-life simulated environment for hands-on practice of interventional endovascular procedures. During the sessions, which were led by key opinion leaders in the field of endovascular procedures in Poland, the physicians used the Simbionix simulators to train and exhibit proficiency in various procedures. Attendees who completed one full endovascular procedure and demonstrated their knowledge and skills in the case steps received certification from the Polish Vascular Society. Training sessions utilized the various practice opportunities offered by the ANGIO Mentor including: carotid stenting, iliac & SFA interventions, renal arteries interventions, as well as virtual abdominal aortic aneurism repairs.

Ran Bronstein, Simbionix President, commented that "The inclusion of the Simbionix ANGIO Mentor in this recent training and certification are a great example of our simulator's benefits in providing a hands-on aspect to practicing patient management and procedure understanding, as well as providing an excellent tool to track learners' records and provide objective assessment. Realistic true to life simulation will be a key factor in the certification of physicians in the future, and we expect such inclusion to become more evident in medical training around the world."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.

    For more information on Simbionix, visit http://www.simbionix.com

    Contact:

    Rebecca Zitter
    Manager of Marketing Communications and Distributor Relations
    Rebecca@simbionix.com
    Tel: +1-216-229-2040



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
2. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
3. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
4. Simbionix Increases Product Offerings for OB/GYN Physicians
5. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
6. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
7. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
8. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
9. Simbionix Launches Innovative Patient-Specific Simulation
10. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
11. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... MANHASSET, N.Y. , Jan. 16, 2017   ... Kevin J. Tracey, MD , president and CEO of ... Northwell Health, completed an analysis of how the nervous ... further identify and develop bioelectronic medicine devices ... today in Nature Neuroscience . The ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today ... will allow more customers to receive their primers in ... or compromise in quality found with other providers. Express ... United States at no additional fee. ... routine genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for Safe ... response to FDA final guidance on biologic ... continued leadership in emphasizing the importance of distinct naming ... aware of the benefits biosimilars will bring to patients, ... Yet the portion of the Guidance dealing with ...
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets has ... to their offering. ... global biopolymers market to grow at a CAGR of 16.83% during the ... the growth prospects of the global biopolymers market for 2017-2021. To calculate ... of sales of biopolymer products. The report also includes a a discussion ...
Breaking Biology Technology:
(Date:12/22/2016)...  As part of its longstanding mission to improve genetic ... recently released its latest children,s book, titled The ... the topics of inheritance and variation of traits that are ... elementary school classrooms in the US. The ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/20/2016)... The rising popularity of mobility services ... stoking significant interest in keyless access systems. Following ... energy (BLE), biometrics and near-field communication (NFC) are ... wireless technologies in the automotive industry. This evolution ... systems opens the market to specialist companies such ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
Breaking Biology News(10 mins):